Floatz logo

Naltrexone

Rheumatoid Arthritis

Truway Health, Inc.Small moleculePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Rheumatoid Arthritis cohort.

Asset / SponsorPhaseRating
METHOTREXATE
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3BB
IBUPROFEN
Amgen
Phase 3BB
Tocilizumab
Hoffmann-La Roche
Phase 3BB
Buprenorphine
Mundipharma Pte Ltd.
Phase 4BB
OLOKIZUMAB
R-Pharm International, LLC
Phase 3BB

View all 38 →

Same molecule, other indications

Naltrexone is also rated in:

alcohol dependenceDormant
BBB
Indicative ·
79 / 100
View asset →
nicotine dependenceDormant
BBB
Indicative ·
76 / 100
View asset →
osteoarthritisDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →